Bacterial resistance to antibiotics in acne vulgaris: An in vitro study

Indian Journal of Dermatology

Volumn 53, Issue 3, 2008, Pages 122-124

  Hassanzadeh, Parvin ^a   Bahmani, M ^b   Mehrabani, Davood ^c  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acne vulgaris; Antibiotic resistance; Rifampin; Southern Iran

Indexed keywords

AMIKACIN; BENZOYL PEROXIDE; CEFALEXIN; CEFALOTIN; CLINDAMYCIN; CLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; NEOMYCIN; RIFAMPICIN; TETRACYCLINE;

ACNE VULGARIS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS; PROPIONIBACTERIUM ACNES; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 53849126122     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.43213     Document Type: Article

References (21)

1. Hanna S, Sharma J, Klotz J. Acne vulgaris: More than skin deep. Dermatol Online J 2003;9:8.
2. Webster GF, Leyden JJ, Nilsson UR. Complement activation in acne vulgaris: Consumption of complement by comedones. Infect Immun 1979;26:183-6.
3. th ed. Oxford Blackwell Science; 2004. p. 43.15.
4. Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M. Acne and smoking: Is there a relationship? BMC Dermatol 2005;24;5:2.
5. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006;12:25.
6. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: A randomized controlled trial. Am J Clin Nutr 2007;86:107-15.
7. Gollnick HP, Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology 2003;206:29-36.
8. Stein RH, Lebwohl M. Acne therapy: Clinical pearls. Semin Cutan Med Surg 2001;20:184-9.
9. nd ed. Toronto: Mozby; 2003. p. 532.
10. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 2003;35:17-24.
11. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001;144:225-7.
12. th ed. The CV Mosby Company; 1990. p. 171-94.
13. Toyoda M, Morohashi M. An overview of topical antibioticforacne treatment. Dermatology 1998;196:130-4.
14. Rodriguez-Cavallini E, Vargas-Dengo P. Etiologyia bacteriana y susceptiblidad a antibioticos en pacientes con acne. Rev Biomed 2004;15:101-6.
15. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med 2000;9:179-87.
16. Leyden JJ. Effect of topical benzoyl peroxide-clindamycin versus topical cindamycin and Propionibacterium acnes. Cutis 2002;69:475-80.
17. Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology 1998;196:69-70.
18. Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol 2006;5:868-70.
19. Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001;145:463-6.
20. Noyon V, Legallou F, Richet H, Dreno B. The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclones. Ann Dermatol Venereol 1998;125:885-7.
21. Tan HH, Goh CL, Yeo MG, Tan ML. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore 2001;30:22-5.